Print

Print


Magnetic Nanotubes May Help Treat Sufferers of Parkinson's and Alzheimer's 
Diseases




  Electrical engineering researchers at the University of Arkansas have 
demonstrated that magnetic nanotubes combined with nerve growth factor can 
enable specific cells to differentiate into neurons. The results from in 
vitro studies show that magnetic nanotubes may be exploited to treat 
neurodegenerative disorders such as Parkinson's disease and Alzheimer's 
disease because they can be used as a delivery vehicle for nerve growth 
factor. 
PC12 cell culture with nerve growth factor-incorporated magnetic nanotubes: 
Micrograph image of a typical PC12 cell with cell body and neurites. The 
inset is a magnified image of the growth cone area.  PC12 cell culture with 
nerve growth factor-incorporated magnetic nanotubes: Micrograph image of a 
typical PC12 cell with cell body and neurites. The inset is a magnified image 
of the growth cone area. 
  “Due to their structure and properties, magnetic nanotubes are among the 
most promising candidates of multifunctional nanomaterials for clinical 
diagnostic and therapeutic applications,” said Jining Xie, research assistant 
professor and lead author of the study. “We're excited about these results 
specifically and the overall promise of functionalized nanotubes to treat 
patients with these debilitating conditions.”
Xie, Linfeng Chen, senior research associate in the Center for Wireless Nano-, 
Bio- and Info-Tech Sensors and Systems, and researchers from Arkansas State 
University worked with rat pheochromocytoma, otherwise known as PC12 cells. 
PC12 cells were chosen because they require nerve growth factor - a small, 
secreted protein that helps nerve cells survive - to differentiate into 
neurons. 
The researchers knew that any sign of nerve growth would indicate interactions 
between the PC12 cells and the nanotubes. They observed neurite growth, 
specifically filopodia - slender projections that extend from the leading 
edge of migrating cells - extruding from neurite growth cones toward the 
nanotubes incorporated with nerve growth factor.
“Microscopic observations showed filopodia extending from the growth cones 
were in close proximity to the nanotubes, at time appearing to reach out 
toward or into them,” Xie said.
The results did not show any abnormal toxicity from the nanotubes.
The human nervous system depends upon a complex network of neurons, or nerve 
cells, tied to each other by synapses. The synaptic connections occur through 
neurites, which are immature or developing neurons. When these connections 
fail, the nervous system does not function properly, eventually leading to 
injury or disease. As Xie mentioned, the researchers hope that functionalized 
nanotubes can help restore or repair damaged nerve cells.
Xie collaborates with Vijay Varadan, distinguished professor of electrical 
engineering and director of the Center for Wireless Nano-, Bio- and Info-Tech 
Sensors and Systems, which is supported by the National Science Foundation's 
Experimental Program to Stimulate Competitive Research. Another collaborator 
was Malathi Srivatsan, associate professor of biology at Arkansas State 
University in Jonesboro, Ark. 
Varadan holds the College of Engineering's Twenty-First Century Endowed Chair 
in Nano- and Bio-Technologies and Medicine and the college's Chair in 
Microelectronics and High Density Electronics. In addition to his position as 
director of the above center, he directs the university's High Density 
Electronics Center. Varadan is also a professor of neurosurgery in the 
College of Medicine at the University of Arkansas for Medical Sciences in 
Little Rock, Ark.
The researchers' findings were published in Nanotechnology, an Institute of 
Physics Publishing journal. An online version of the article is available at 
http://www.iop.org/EJ/abstract/-search=60067076.1/0957-4484/19/10/105101 .

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn